Literature DB >> 2106315

The effect of N-linked glycosylation on the substrate preferences of UDP glucuronosyltransferases.

P I Mackenzie1.   

Abstract

The presence of potential N-linked glycosylation sites (Asn-X-Ser/Thr) in two forms of UDP glucuronosyltransferase, designated UDPGTr-2 and UDPGTr-4, has been deduced from cDNA sequence data. These forms were glycosylated when synthesized from expression vectors transfected into COS cells and were converted to faster migrating species on SDS polyacrylamide gels when treated with endoglycosidase H. The role of glycosylation was investigated by determining the substrate specificities and stabilities of the glycosylated enzymes and their unglycosylated variants which were synthesized in the presence of tunicamycin. Analysis of the activities towards 13 different aglycones showed that the glycosyl moiety was not essential for catalytic activity and had no effect on the substrate preference of each form. The stabilities of the proteins were not adversely affected by the absence of this posttranslational modification. A possible effect of N-linked oligosaccharides on the catalytic properties of these two forms of UDP glucuronosyltransferase is discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2106315     DOI: 10.1016/0006-291x(90)91006-e

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Cloning and characterization of a simian UDP-glucuronosyltransferase enzyme UGT2B20, a novel C19 steroid-conjugating protein.

Authors:  O Barbier; A Bélanger; D W Hum
Journal:  Biochem J       Date:  1999-02-01       Impact factor: 3.857

2.  Introduction of an N-Glycosylation Site into UDP-Glucuronosyltransferase 2B3 Alters Its Sensitivity to Cytochrome P450 3A1-Dependent Modulation.

Authors:  Tatsuro Nakamura; Naho Yamaguchi; Yuu Miyauchi; Tomoki Takeda; Yasushi Yamazoe; Kiyoshi Nagata; Peter I Mackenzie; Hideyuki Yamada; Yuji Ishii
Journal:  Front Pharmacol       Date:  2016-11-14       Impact factor: 5.810

3.  Use of a Baculovirus-Mammalian Cell Expression-System for Expression of Drug-Metabolizing Enzymes: Optimization of Infection With a Focus on Cytochrome P450 3A4.

Authors:  Yuu Miyauchi; Akane Kimura; Madoka Sawai; Keiko Fujimoto; Yuko Hirota; Yoshitaka Tanaka; Shinji Takechi; Peter I Mackenzie; Yuji Ishii
Journal:  Front Pharmacol       Date:  2022-02-22       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.